Careers
Contact
Company
Company
Management
Board of Directors
Scientific Advisors
Technology
Technology Platform
Cancer
Infectious Diseases
Scientific Presentations
Pipeline
Pipeline
VB10.16
VB10.NEO
Others
Partnering & Investors
Partnering
Investor Relations
News & Events
News
Media
Upcoming Events
Company
Company
Management
Board of Directors
Scientific Advisors
Technology
Technology Platform
Cancer
Infectious Diseases
Scientific Presentations
Pipeline
Pipeline
VB10.16
VB10.NEO
Others
Partnering & Investors
Partnering
Investor Relations
News & Events
News
Media
Upcoming Events
Vaccibody.com | Media
941
page-template-default,page,page-id-941,ajax_updown_fade,page_not_loaded,,qode-title-hidden,qode-child-theme-ver-,qode-theme-ver-16.6,qode-theme-bridge,disabled_footer_top,wpb-js-composer js-comp-ver-5.5.5,vc_responsive
VACCIBODY IN THE MEDIA
Prestigious partnership for Vaccibody
Published: Sep 27, 2018 – Oslo Cancer Cluster
‘Vaccibody’s therapeutic HPV vaccine obtains proof-of-concept in phase 2a study’
Vaccibodys terapeutiske HPV-vaccine opnår proof-of-concept i fase 2a-studie
Published: Sep 27, 2018 – Medwatch
‘Norwegian company of Danish biotech veteran enters collaboration with BMS partner’
Dansk biotekveterans norske selskab indgår samarbejde med BMS-partner
Published: Sep 21, 2018 – Medwatch
‘Breakthrough – Norwegian company with new world-class cancer vaccine’
Norsk firma med ny kreftvaksine i verdensklasse: – Revolusjonerende
Published: Apr 11, 2018 – VG
‘Vaccibody is getting ready for Phase I with new data’
Vaccibody varmer op til fase 1 med nye data
Published: Jan 10, 2018 – Medwatch
‘Vaccibody to initiate new clinical trial and to start hunt for partner’
Vaccibody laver nye kliniske fremstød og starter partnerjagt
Published: Dec 13, 2017 – Medwatch
‘Norwegian world-class vaccine technology’
Norsk vaksineteknologi i verdenstoppen
Published: Sep 14, 2017 – Kreftforeningen
‘Norwegian company with new vaccine technology’
Norsk firma med ny vaksineteknologi
Published: May 8, 2017 – Bioteknologirådet
Vaccibody moves forward with clinical study
Published: Apr 10, 2017 – Nordic Life Science
Inven2 – Company presentation
Published: Feb 14, 2017 – Inven2
‘Investors queuing up for cancer vaccine’
Investorer i kø for kreftvaksine
Published: Jan 26, 2017 – Finansavisen
‘
Queue to buy shares’
Kø for å kjøpe aksjer i kreftselskap – Da Vaccibody ba om 200 millioner kroner til en ny kreftvaksine, kom investorene løpende
Published: Jan 26, 2017 – Dagbladet
‘Has already saved lives: Agnete (38) can revolutionize future cancer treatment’
Har allerede reddet liv: Agnete (38) kan revolusjonere fremtidens kreftbehandling
Published: Oct 2, 2016 – TV2
‘Norwegian vaccine breakthrough’
Norsk vaksine-gjennombrudd: Har begynt testing på mennesker – Utenpå var jeg voksen og ordentlig, men inni meg var det høy puls.
Published: Sep 17, 2015 – Teknisk Ukeblad
Vaccibody name Martin Bonde as CEO
Published: Jul 1, 2015 – PMLive
‘Creating intelligent vaccines that might cure cancer’
Lager intelligent vaksine de håper kan kurere kreft #NorgeEtterOljen.
Published: Feb 8, 2015 – Teknisk Ukeblad
From the lab to vaccines that fight cancer and infectious diseases
Published: Jan 25, 2016 – UiO:Life Science
‘Agnete (37) is ready to test Norwegian cancer vaccine in humans’
Agnete (37) er klar for å teste norsk kreftvaksine på mennesker – Etter svært lovende resultater i forsøk på dyr, skal en norsk vaksine mot livmorhalskreft nå testes på mennesker.
Published: Jun 15, 2015 – TV2